Phosphorescent heteroleptic phenylbenzimidazole dopants

US9212197B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9212197-B2
Application numberUS-201113111490-A
CountryUS
Kind codeB2
Filing dateMay 19, 2011
Priority dateMay 19, 2011
Publication dateDec 15, 2015
Grant dateDec 15, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel phosphorescent heteroleptic iridium complexes with benzimidazole and phenylpyridine ligands are provided. These iridium complexes can improve OLED properties, and are useful in white light applications.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound comprising a heteroleptic iridium complex having the formula: wherein R 1 , R 3 , R 4 , R 5 , and R 6 represent mono-, di-, tri- or tetra-substitution; wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R 1 , R 3 , R 4 , R 5 , and R 6 are optionally fused and may be further substituted; wherein (1) R 6 is alkyl or heteroalkyl at a position para to a pyridine bonded to iridium, or (2) R 6 is fused and, optionally, further substituted, or (3) both conditions (1) and (2) are satisfied; and wherein n=1 or 2. 2. The compound of claim 1 , wherein n=2. 3. The compound of claim 1 , wherein n=1. 4. The compound of claim 1 , wherein R 2 is aryl or substituted aryl. 5. The compound of claim 4 , wherein R 2 is a 2,6-disubstituted aryl. 6. The compound of claim 5 , wherein R 2 is 7. The compound of claim 1 , wherein R 2 is alkyl. 8. The compound of claim 1 , wherein R 3 , R 4 , R 5 and R 6 are each independently selected from the group consisting of hydrogen and alkyl, and wherein at least one of R 3 , R 4 , R 5 and R 6 is alkyl. 9. The compound of claim 1 , wherein R 5 is aryl. 10. The compound of claim 1 , wherein R 6 is fused to form a naphthyl or aza-naphthyl ring system. 11. The compound of claim 1 , wherein R 1 , R 3 , and R 5 are hydrogen. 12. The compound of claim 1 , wherein the compound is selected from the group consisting of: 13. A first device comprising a first organic light emitting device, comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a compound having the formula: wherein R 1 , R 3 , R 4 , R 5 , and R 6 represent mono-, di-, tri- or tetra-substitution; wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R 1 , R 3 , R 4 , R 5 , and R 6 are optionally fused and may be further substituted; wherein (1) R 6 is alkyl or heteroalkyl at a position para to a pyridine bonded to iridium, or (2) R 6 is fused and, optionally, further substituted, or (3) both conditions (1) and (2) are satisfied; and wherein n=1 or 2. 14. The first device of claim 13 , wherein the organic layer is an emissive layer and the compound is an emissive dopant. 15. The first device of claim 13 , wherein the organic layer is an emissive layer and the compound is a non-emissive dopant. 16. The first device of claim 13 , wherein the organic layer further comprises a host. 17. The first device of claim 16 , wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C n H 2n+1 , OC n H 2n+1 , OAr 1 , N(C n H 2n+1 ) 2 , N(Ar 1 )(Ar 2 ), CH═CH—C n H 2n+1 , C≡CC n H 2n+1 , Ar 1 , Ar 1 —Ar 2 , C n H 2n —Ar 1 , or no substitution; wherein n is from 1 to 10; and wherein Ar 1 and Ar 2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. 18. The first device of claim 17 , wherein the host has the formula: 19. The first device of claim 16 , wherein the host is a metal complex. 20. The first device of claim 13 wherein the first device is a consumer product. 21. The first device of claim 13 , wherein the first device is an organic light-emitting device. 22. The first device of claim 13 , wherein the first device further comprises a second emissive dopant having a peak wavelength of between 400 to 500 nanometers. 23. The first device of claim 22 , wherein the second emissive dopant is a fluorescent emitter. 24. The first device of claim 22 , wherein the second emissive dopant is a phosphorescent emitter. 25. The first device of claim 13 , wherein the first device comprises a lighting panel. 26. The first device of claim 13 , wherein the first device further comprises a first organic light-emitting device comprising a compound of Formula I and a second light emitting device separate from the first organic light-emitting device comprising an emissive dopant having a peak wavelength of between 400 to 500 nanometers. 27. The first device of claim 13 , wherein the first device comprises an organic-light emitting device having a first emissive layer and a second emissive layer; wherein the first emissive layer comprises a compound

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9212197B2 cover?
Novel phosphorescent heteroleptic iridium complexes with benzimidazole and phenylpyridine ligands are provided. These iridium complexes can improve OLED properties, and are useful in white light applications.
Who is the assignee on this patent?
Kottas Gregg, Xia Chuanjun, Elshenawy Zeinab, and 2 more
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).